期刊文献+

Hepato-cardiac disorders 被引量:10

Hepato-cardiac disorders
下载PDF
导出
摘要 Understanding the mutual relationship between the liver and the heart is important for both hepatologists and cardiologists. Hepato-cardiac diseases can be classified into heart diseases affecting the liver, liver diseases affecting the heart, and conditions affecting the heart and the liver at the same time. Differential diagnoses of liver injury are extremely important in a cardiologist's clinical practice calling for collaboration between cardiologists and hepatologists due to the many other diseases that can affect the liver and mimic haemodynamic injury. Acute and chronic heart failure may lead to acute ischemic hepatitis or chronic congestive hepatopathy. Treatment in these cases should be directed to the primary heart disease. In patients with advanced liver disease, cirrhotic cardiomyopathy may develop including hemodynamic changes, diastolic and systolic dysfunctions, reduced cardiac performance and electrophysiological abnormalities. Cardiac evaluation is important for patients with liver diseases especially before and after liver transplantation. Liver transplantation may lead to the improvement of all cardiac changes and the reversal of cirrhotic cardiomyopathy. There are systemic diseases that may affect both the liver and the heart concomitantly including congenital, metabolic and inflammatory diseases as well as alcoholism. This review highlights these hepatocardiac Understanding the mutual relationship between the liver and the heart is important for both hepatologists and cardiologists. Hepato-cardiac diseases can be classified into heart diseases affecting the liver, liver diseases affecting the heart, and conditions affecting the heart and the liver at the same time. Differential diagnoses of liver injury are extremely important in a cardiologist’s clinical practice calling for collaboration between cardiologists and hepatologists due to the many other diseases that can affect the liver and mimic haemodynamic injury. Acute and chronic heart failure may lead to acute ischemic hepatitis or chronic congestive hepatopathy. Treatment in these cases should be directed to the primary heart disease. In patients with advanced liver disease, cirrhotic cardiomyopathy may develop including hemodynamic changes, diastolic and systolic dysfunctions, reduced cardiac performance and electrophysiological abnormalities. Cardiac evaluation is important for patients with liver diseases especially before and after liver transplantation. Liver transplantation may lead to the improvement of all cardiac changes and the reversal of cirrhotic cardiomyopathy. There are systemic diseases that may affect both the liver and the heart concomitantly including congenital, metabolic and inflammatory diseases as well as alcoholism. This review highlights these hepatocardiac diseases
出处 《World Journal of Hepatology》 CAS 2014年第1期41-54,共14页 世界肝病学杂志(英文版)(电子版)
关键词 CARDIAC CIRRHOSIS ISCHEMIC hepatitis FATTY LIVER LIVER CIRRHOSIS Heart failure Cardiac cirrhosis Ischemic hepatitis Fatty liver Liver cirrhosis Heart failure
  • 相关文献

参考文献55

  • 1Mercedes Susan Mandell,JoAnn Lindenfeld,Mei-Yung Tsou,Michael Zimmerman.Cardiac evaluation of liver transplant candidates[J].World Journal of Gastroenterology,2008,14(22):3445-3451. 被引量:8
  • 2S?ren M?ller,Mauro Bernardi.Interactions of the heart and the liver[J]. European Heart Journal . 2013 (36) 被引量:1
  • 3C.‐S. Hsu,J.‐H. Kao,Y.‐C. Chao,H. H. Lin,Y.‐C. Fan,C.‐J. Huang,P.‐S. Tsai.Interferon‐based therapy reduces risk of stroke in chronic hepatitis C patients: a population‐based cohort study in Taiwan[J]. Aliment Pharmacol Ther . 2013 (4) 被引量:1
  • 4Ausra Kavoliuniene,Audrone Vaitiekiene,Giedre Cesnaite.Congestive hepatopathy and hypoxic hepatitis in heart failure: A cardiologist’s point of view[J]. International Journal of Cardiology . 2013 (3) 被引量:1
  • 5Z. M. Younossi,M. Stepanova,F. Nader,Z. Younossi,E. Elsheikh.Associations of chronic hepatitis C with metabolic and cardiac outcomes[J]. Aliment Pharmacol Ther . 2013 (6) 被引量:1
  • 6Ichiro Miyajima,Takumi Kawaguchi,Ako Fukami,Yumiko Nagao,Hisashi Adachi,Satoshi Sasaki,Tsutomu Imaizumi,Michio Sata.Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area[J]. Journal of Gastroenterology . 2013 (1) 被引量:1
  • 7Junlan Zhang,Wenli Yang,Bao Luo,Bingqian Hu,Akhil Maheshwari,Michael B. Fallon.The role of CX 3 CL1/CX 3 CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome[J]. Journal of Hepatology . 2012 (4) 被引量:1
  • 8Jonathan A. Yang,Tomoko S. Kato,Brittney P. Shulman,Hiroo Takayama,Maryjane Farr,Ulrich P. Jorde,Donna M. Mancini,Yoshifumi Naka,P. Christian Schulze.Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system[J]. Journal of Heart and Lung Transplantation . 2012 (6) 被引量:1
  • 9Aalap Chokshi,Faisal H. Cheema,Kenneth J. Schaefle,Jeffrey Jiang,Elias Collado,Khurram Shahzad,Tuba Khawaja,Maryjane Farr,Hiroo Takayama,Yoshifumi Naka,Donna M. Mancini,P. Christian Schulze.Hepatic dysfunction and survival after orthotopic heart transplantation: Application of the MELD scoring system for outcome prediction[J]. Journal of Heart and Lung Transplantation . 2012 (6) 被引量:1
  • 10Luigi E. Adinolfi,Luciano Restivo,Rosa Zampino,Barbara Guerrera,Amedeo Lonardo,Laura Ruggiero,Francesco Riello,Paola Loria,Anna Florio.Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis[J]. Atherosclerosis . 2012 (2) 被引量:2

二级参考文献62

  • 1[1]Turner TB,Bennett VL,Hernandez H.The beneficial side of moderate alcohol use.Johns Hopkins Med J 1981; 148:53-63 被引量:1
  • 2[2]Snowden CP,Hughes T,Rose J,Roberts DR.Pulmonary edema in patients after liver transplantation.Liver Transpl 2000; 6:466-470 被引量:1
  • 3[3]Donovan CL,Marcovitz PA,Punch JD,Bach DS,Brown KA,Lucey MR,Armstrong WF.Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation.Transplantation 1996; 61:1180-1188 被引量:1
  • 4[4]Mann J,Davies MJ.Mechanisms of progression in native coronary artery disease:role of healed plaque disruption.Heart 1999; 82:265-268 被引量:1
  • 5[5]Nagoshi T,Koiwaya Y,Doi H,Eto T.Angiographic coronary morphology in patients with ischemic heart disease.J Cardiol 2000; 36:91-102 被引量:1
  • 6[6]Carey WD,Dumot JA,Pimentel RR,Barnes DS,Hobbs RE,Henderson JM,Vogt DP,Mayes JT,Westveer MK,Easley KA.The prevalence of coronary artery disease in liver transplant candidates over age 50.Transplantation 1995; 59:859-864 被引量:1
  • 7[7]Plotkin JS,Scott VL,Pinna A,Dobsch BP,De Wolf AM,Kang Y.Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation.Liver Transpl Surg 1996; 2:426-430 被引量:1
  • 8[8]Morris JJ,Hellman CL,Gawey BJ,Ramsay MA,Valek TR,Gunning TC,Swygert TH,Shore-Lesserson L,Lalehzarian F,Brayman KL.Case 3-1995.Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation.J Cardiothorac Vasc Anesth 1995; 9:322-332 被引量:1
  • 9[9]Tiukinhoy-Laing SD,Rossi JS,Bayram M,De Luca L,Gafoor S,Blei A,Flamm S,Davidson CJ,Gheorghiade M.Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation.Am J Cardiol 2006; 98:178-181 被引量:1
  • 10[10]United Network for Organ Sharing Organ Procurement:Available at The U.S.Transplant Network/Scientific Registry of Transplant Recipients 2006 Annual report:Transplant data.Available from:URL:http://www.ustransplant.org/annual_reports/current/survival_rates.htm 被引量:1

共引文献10

同被引文献69

引证文献10

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部